David E. Morris

2.6k total citations
50 papers, 1.9k citations indexed

About

David E. Morris is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, David E. Morris has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 12 papers in Genetics. Recurrent topics in David E. Morris's work include Lung Cancer Diagnosis and Treatment (21 papers), Lung Cancer Treatments and Mutations (20 papers) and Lung Cancer Research Studies (13 papers). David E. Morris is often cited by papers focused on Lung Cancer Diagnosis and Treatment (21 papers), Lung Cancer Treatments and Mutations (20 papers) and Lung Cancer Research Studies (13 papers). David E. Morris collaborates with scholars based in United States, Türkiye and Belgium. David E. Morris's co-authors include Mark A. Socinski, Julian Rosenman, Jan Halle, Dominic T. Moore, Thomas A. Hensing, Frank C. Detterbeck, Daniel B. Fried, John C. Flíckinger, James A. Hayman and Leland Rogers and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

David E. Morris

50 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Morris United States 20 1.3k 774 431 413 391 50 1.9k
Chad G. Rusthoven United States 29 1.7k 1.3× 1.0k 1.3× 254 0.6× 417 1.0× 327 0.8× 104 2.4k
Kirtesh R. Patel United States 25 1.4k 1.0× 957 1.2× 518 1.2× 195 0.5× 804 2.1× 83 2.1k
Rodney E. Wegner United States 24 907 0.7× 782 1.0× 457 1.1× 229 0.6× 362 0.9× 174 2.2k
James J. Urbanic United States 27 2.6k 1.9× 1.4k 1.8× 778 1.8× 813 2.0× 827 2.1× 86 3.2k
M. Hatton United Kingdom 25 2.2k 1.6× 2.0k 2.6× 1.0k 2.4× 473 1.1× 171 0.4× 96 3.3k
M. Snee United Kingdom 18 2.2k 1.6× 1.4k 1.8× 840 1.9× 157 0.4× 126 0.3× 48 2.8k
Russell K. Hales United States 22 817 0.6× 631 0.8× 235 0.5× 236 0.6× 103 0.3× 93 1.5k
Koichi Tokuuye Japan 34 1.8k 1.4× 591 0.8× 813 1.9× 893 2.2× 265 0.7× 157 3.5k
Jian Z. Wang United States 29 1.8k 1.3× 496 0.6× 216 0.5× 1.3k 3.2× 357 0.9× 51 2.9k
Jean-Paul Bahary Canada 19 2.8k 2.1× 1.0k 1.3× 590 1.4× 801 1.9× 1.1k 2.9× 104 3.3k

Countries citing papers authored by David E. Morris

Since Specialization
Citations

This map shows the geographic impact of David E. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Morris more than expected).

Fields of papers citing papers by David E. Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Morris. The network helps show where David E. Morris may publish in the future.

Co-authorship network of co-authors of David E. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Morris. A scholar is included among the top collaborators of David E. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Morris. David E. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Blatt, Julie, et al.. (2013). Mucoepidermoid Carcinoma of the Parotid as a Secondary Malignancy After Chemotherapy in a Child With Neuroblastoma. Journal of Pediatric Hematology/Oncology. 35(5). 399–401. 9 indexed citations
3.
Fried, David, Adam M. Zanation, Benjamin Huang, et al.. (2012). Patterns of local failure for sinonasal malignancies. Practical Radiation Oncology. 3(3). e113–e120. 12 indexed citations
4.
Kimple, Randall J., et al.. (2010). Concurrent Temozolomide and Radiation, a Reasonable Option for Elderly Patients With Glioblastoma Multiforme?. American Journal of Clinical Oncology. 33(3). 265–270. 34 indexed citations
5.
Erickson, Bradley A., D. Jeffrey Demanes, Geoffrey S. Ibbott, et al.. (2010). American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of High-Dose-Rate Brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 79(3). 641–649. 33 indexed citations
6.
Higginson, Daniel S., David E. Morris, Ellen L. Jones, Daniel L. Clarke‐Pearson, & Mahesh A. Varia. (2010). Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology. Gynecologic Oncology. 120(3). 404–412. 57 indexed citations
7.
Lee, Carrie B., Thomas E. Stinchcombe, Dominic T. Moore, et al.. (2009). Late Complications of High-Dose (≥66 Gy) Thoracic Conformal Radiation Therapy in Combined Modality Trials in Unresectable Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 4(1). 74–79. 35 indexed citations
8.
Ewend, Matthew G., David E. Morris, Lisa A. Carey, Alim Ladha, & Steven Brem. (2008). Guidelines for the Initial Management of Metastatic Brain Tumors: Role of Surgery, Radiosurgery, and Radiation Therapy. Journal of the National Comprehensive Cancer Network. 6(5). 505–514. 51 indexed citations
9.
Das, Prajnan, Andrea K. Ng, Louis S. Constine, et al.. (2008). ACR Appropriateness Criteria® on Hodgkin's Lymphoma—Favorable Prognosis Stage I and II. Journal of the American College of Radiology. 5(10). 1054–1066. 3 indexed citations
10.
Socinski, Mark A., Thomas E. Stinchcombe, D. Neil Hayes, & David E. Morris. (2006). The Emergence of a Unique Population in Non–Small Cell Lung Cancer: Systemic or Loco-Regional Relapse Following Postoperative Adjuvant Platinum-Based Chemotherapy. Seminars in Oncology. 33(1 Suppl 1). 32–38. 1 indexed citations
11.
Stinchcombe, Thomas E., David E. Morris, Dominic T. Moore, et al.. (2006). Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy. Lung Cancer. 52(1). 67–74. 24 indexed citations
12.
Lee, Carrie B., David E. Morris, Daniel B. Fried, & Mark A. Socinski. (2006). Current and evolving treatment options for limited stage small cell lung cancer. Current Opinion in Oncology. 18(2). 162–172. 14 indexed citations
13.
Mehta, Minesh P., May Tsao, Timothy J. Whelan, et al.. (2005). The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. International Journal of Radiation Oncology*Biology*Physics. 63(1). 37–46. 258 indexed citations
14.
Morris, David E., Bahman Emami, Peter Mauch, et al.. (2005). Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: An ASTRO outcomes initiative. International Journal of Radiation Oncology*Biology*Physics. 62(1). 3–19. 45 indexed citations
15.
Socinski, Mark A., David E. Morris, Gregory A. Masters, & Rogério Lilenbaum. (2003). Chemotherapeutic Management of Stage IV Non-small Cell Lung Cancer*. CHEST Journal. 123(1). 226S–243S. 159 indexed citations
16.
Rosenman, Julian, Jan Halle, Mark A. Socinski, et al.. (2002). High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. International Journal of Radiation Oncology*Biology*Physics. 54(2). 348–356. 164 indexed citations
17.
Morris, David E., J. Daniel Bourland, Julian Rosenman, & Edward G. Shaw. (2001). Three-dimensional conformal radiation treatment planning and delivery for low- and intermediate-grade gliomas. Seminars in Radiation Oncology. 11(2). 124–137. 15 indexed citations
18.
Lorelli, David R., David E. Morris, & Joseph W. Lewis. (2001). Drug-induced methemoglobinemia during thoracoscopic lung biopsy. The Annals of Thoracic Surgery. 71(2). 703–705. 6 indexed citations
19.
Ewend, Matthew G., Lisa A. Carey, David E. Morris, R. Donald Harvey, & Thomas A. Hensing. (2001). Brain metastases. Current Treatment Options in Oncology. 2(6). 537–547. 20 indexed citations
20.
Morris, David E.. (1982). An Introductory Examination of the Racketeer Influenced and Corrupt Organizations Act. Akron law review. 15(4). 8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chad G. Rusthoven Breakdown of academic impact, for papers by Kirtesh R. Patel Breakdown of academic impact, for papers by Rodney E. Wegner Breakdown of academic impact, for papers by James J. Urbanic Breakdown of academic impact, for papers by M. Hatton Breakdown of academic impact, for papers by M. Snee Breakdown of academic impact, for papers by Russell K. Hales Breakdown of academic impact, for papers by Koichi Tokuuye Breakdown of academic impact, for papers by Jian Z. Wang Breakdown of academic impact, for papers by Jean-Paul Bahary
Rankless by CCL
2026